INNOVA CAPTAB
Back to Income Statement
|
INNOVA CAPTAB Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹1,081 Cr | ₹926 Cr | ₹801 Cr | ₹411 Cr | ₹373 Cr |
What is the latest Revenue of INNOVA CAPTAB ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹1,081 Cr |
| Mar2024 | ₹926 Cr |
| Mar2023 | ₹801 Cr |
| Mar2022 | ₹411 Cr |
| Mar2021 | ₹373 Cr |
How is Revenue of INNOVA CAPTAB Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,081 Cr | 16.72 | |
| Mar2024 | ₹926 Cr | 15.72 | |
| Mar2023 | ₹801 Cr | 94.94 | |
| Mar2022 | ₹411 Cr | 10.00 | |
| Mar2021 | ₹373 Cr | - | |
Compare Revenue of peers of INNOVA CAPTAB
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INNOVA CAPTAB | ₹4,132.4 Cr | -1.5% | 1.3% | -18.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹399,549.0 Cr | -1.9% | -7.3% | -2.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,862.0 Cr | 1.8% | 3.3% | 9.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹139,912.0 Cr | -0.5% | -4% | 29.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,891.0 Cr | 0.2% | -4.9% | 6.6% | Stock Analytics | |
| CIPLA | ₹99,591.5 Cr | 0.5% | -3.8% | -17% | Stock Analytics | |
INNOVA CAPTAB Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INNOVA CAPTAB | -1.5% |
1.3% |
-18.6% |
| SENSEX | 3.2% |
5% |
5.5% |
You may also like the below Video Courses